Technology | Breast Biopsy Systems | August 31, 2017

System offers real-time imaging of tissue samples, resulting in major cost and time savings

Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology

August 31, 2017 — Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging technology, a real-time breast biopsy and verification system. The system enhances workflow, improves the patient experience and streamlines the entire biopsy process from start to finish. It is designed to increase biopsy accuracy with real-time imaging that delivers valuable information at the point of care, enabling clinicians to make informed decisions with confidence.

The Brevera system is the world's first and only breast biopsy solution to combine tissue acquisition, real-time imaging, sample verification and advanced post-biopsy handling in one, integrated system, according to Hologic. Designed for 2-D and 3-D breast biopsy, the system allows physicians to perform fast and efficient procedures that save costs and improve the patient experience.1 

Until now, radiologists performing stereotactic breast biopsy procedures to diagnose breast cancer were often required to leave the patient under compression while they moved to another room to image and verify tissue samples. This leads to lengthy procedure times and anxious, uncomfortable patients, and can interrupt facility screening schedules. With the Brevera system, radiologists are able to obtain and image tissue samples in the procedure room in just a few seconds, potentially saving up to 10 minutes per patient and cutting the procedure time by up to 25 percent.2

In addition to saving facility resources and physician time during a breast biopsy procedure, the Brevera system's proprietary CorLumina imaging technology helps enhance workflow across multiple departments within a health system. The system automates the tissue sample collection and separation process, which allows patient tissue to be sent to pathology with little or no manual handling and protects the integrity of samples. The system also features picture archiving and communication system (PACS) integration for advanced image sharing and transfer of patient records.

The Brevera system is designed for use with Hologic's Affirm prone biopsy system, Affirm breast biopsy guidance system and MultiCare Platinum system, as well as most upright and prone systems on the market.

For more information: www.hologic.com

 

References

1. 3-D biopsy only when used with the Affirm breast biopsy system. 
2. 2015 Kadence International survey of 200 healthcare professionals.


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
Subscribe Now